|
RTW Biotech Opportunities Ltd - Guernsey-based investor in life sciences sector - Adds $15 million to share buyback programme, aiming to close the discount of its share price to net asset value. RTW Biotech has $5.8 million to complete from its current $30 million buyback and will top that up by $15 million, which is equivalent to about 9.2 million shares. Funds for the buyback come from several recent realisations of portfolio holdings. The company’s most recently report net asset value, as of June 30, was $1.70. Current stock price: $1.62 12-month change: up 3.9% Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
